🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
MEK is a critical member of the MAPK pathway involved in growth and surviva...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2005-11
Trial ID
NCT00174369
Treatments Being Tested
This phase II open label study will evaluate adolescents (≥ 16 years of age...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2014-06
Trial ID
NCT02096471
Treatments Being Tested
The purpose of this study is to find out whether mirdametinib in combinatio...
Status
Recruiting
Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Start Date
2025-02-19
Trial ID
NCT06843967
Treatments Being Tested
This is an open-label, multi-center, Phase 1/2 study of the brain-penetrant...
Status
Recruiting
Location
St. Jude Children's Research Hospital
Start Date
2021-06-21
Trial ID
NCT04923126
Treatments Being Tested
This research study is evaluating the experimental drug palbociclib in comb...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2014-01
Trial ID
NCT02022982
Treatments Being Tested
Monocentric study composed by 2 steps : 1. First step is a phase I with th...
Status
Recruiting
Location
Centre Georges-François Leclerc
Start Date
2026-07-07
Trial ID
NCT05937906
Recent studies have demonstrated that growth of vascular malformations can ...
Status
Recruiting
Location
Peter MacCallum Cancer Centre
Start Date
2024-09-13
Trial ID
NCT05983159
Treatments Being Tested
This trial is designed to try two new cancer drugs together for the first t...
Status
Completed
Location
Oxford University Hospital NHS Trust
Start Date
2014-11
Trial ID
NCT02510001
Treatments Being Tested
This is a Phase 1/2a, open-label, non-randomized, multi-dose study of mirda...
Status
Recruiting
Location
Johns Hopkins Hospital
Start Date
2024-02-12
Trial ID
NCT06159166
Treatments Being Tested
This phase II trial tests the effect of mirdametinib in treating patients w...
Status
Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2026-05-27
Trial ID
NCT07061951
Treatments Being Tested